Your session is about to expire
← Back to Search
MRI Brain and Cervical Spine for Multiple Sclerosis
Study Summary
This trial uses USPIO nanoparticles and MRI to measure activity in the innate immune system within MS lesions, in order to find a biomarker for chronic-active lesions.
- Secondary Progressive Multiple Sclerosis
- Multiple Sclerosis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are being recruited into this investigation?
"Indeed, as per clinicaltrials.gov's listing, this research initiative is currently searching for volunteers. The trial was first published on June 1st 2022 and was recently updated on June 22nd 2022. Its goal is to find 10 individuals from one location."
Does this investigation have an age cap for participation?
"Participants must be within the age range of 35 - 65 in order to meet this trial's enrollment requirements."
Am I eligible to be a part of this research endeavor?
"Applicants must suffer from multiple sclerosis and be between the ages of 35-65 to qualify for this medical trial. The total number of participants is capped at 10 individuals."
Are there any openings still available to participate in this research?
"Affirmative. Clinicaltrials.gov indicates that this medical trial is presently seeking participants, having been first posted on June 1st 2022 and recently edited on the 22nd of the same month. The research requires 10 people to be enrolled at one site."
Share this study with friends
Copy Link
Messenger